New Market Research Report: Hodgkin Lymphoma - Pipeline Review, H1 2012

2012-02-08 07:53:50 - New Pharmaceuticals market report from Global Markets Direct: "Hodgkin Lymphoma - Pipeline Review, H1 2012"

Hodgkin Lymphoma - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Hodgkin Lymphoma - Pipeline Review, H1 2012', provides an overview of the Hodgkin Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hodgkin

Lymphoma. 'Hodgkin Lymphoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at
- www.fastmr.com/prod/330102_hodgkin_lymphoma_pipeline_review_h1_2 ..


Scope

* A snapshot of the global therapeutic scenario for Hodgkin Lymphoma.
* A review of the Hodgkin Lymphoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Hodgkin Lymphoma pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Hodgkin Lymphoma.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Hodgkin Lymphoma pipeline depth and focus of Hodgkin Lymphoma therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hodgkin Lymphoma Overview
Therapeutics Development
An Overview of Pipeline Products for Hodgkin Lymphoma
Hodgkin Lymphoma Therapeutics under Development by Companies
Hodgkin Lymphoma Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Hodgkin Lymphoma Therapeutics - Products under Development by Companies
Hodgkin Lymphoma Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Hodgkin Lymphoma Therapeutics Development
Bristol-Myers Squibb Company
Genzyme Corporation
Sanofi-Aventis
Seattle Genetics, Inc.
Gilead Sciences, Inc.
Daiichi Sankyo Company, Ltd
Merck & Co., Inc.
Gamida Cell Ltd.
Celltrion, Inc.
ZIOPHARM Oncology, Inc.
Novartis AG
Cephalon, Inc.
4SC AG
Hana Biosciences, Inc.
MethylGene Inc
Keryx Biopharmaceuticals, Inc.
Allos Therapeutics, Inc
Cytokinetics, Inc
Pharmacyclics, Inc.
Digna Biotech, S.L.
Affimed Therapeutics AG
Philogen S.p.A.
S*BIO Pte Ltd
Syndax Pharmaceuticals, Inc.
Xencor, Inc.
Aprea AB.
Archer Biosciences, Inc
Hodgkin Lymphoma - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
StemEx - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adcetris - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adcetris - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LBH589 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adriamycin + Bleomycin + Vincristine + Dacarbazine + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bleomycin Sulfate + Cyclophosphamide + Doxorubicin Hydrochloride + Etoposide + Prednisone + Vincristine Sulfate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Filgrastim + Cisplatin + Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin Hydrochloride + Etoposide Phosphate + Ifosfamide + Prednisone + Vincristine Sulfate + Vinorelbine Ditartrate + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adriamycin + Bleomycin + Vinblastine + Dacarbazine + Carmustine + Etoposide + Methylprednisolone + Vincristine Sulfate + Vindesine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Carmustine + Cisplatin + Cytarabine + Dexamethasone + Adiramycin + Etoposide + Gemcitabine Hydrochloride + Ifosfamide + Melphalan + Methylprednisolone + Mitoguazone + Vindesine + Vinorelbine Ditartrate + Allogeneic Stem Cell Transplantation + Autologous Stem Cell Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Adriamycin + Bleomycin + Vinblastine + Dacarbazine - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=330102&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.